TMCI
TMCI
NASDAQ · Health Care

Treace Medical Concepts Inc

$2.30
+0.36 (+18.30%)
As of May 16, 2:09 AM ET ·
Financial Highlights (FY 2026)
Revenue
263.22M
Net Income
-73,022,437
Gross Margin
79.8%
Profit Margin
-27.7%
Rev Growth
+14.5%
D/E Ratio
0.64
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 263.22M 229.95M 42.92M 46.18M
Gross Profit 210.08M 183.52M 23.26M 25.03M
Operating Income -70,411,509 -55,359,795 7.80M 8.54M
Net Income -73,022,437 -57,412,591 5.79M 5.86M
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Rev Growth +14.5% +14.5% +24.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 34.95M 34.95M 8.48M 7.21M
Total Equity 54.90M 54.90M 83.95M 82.42M
D/E Ratio 0.64 0.64 0.10 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -56,728,239 -47,079,433 10.44M 11.89M
Free Cash Flow 4.81M 4.94M